Knowledge Transfer | Department of Applied Biology and Chemical Technology

Facts & Figures

>60

Researchers

Active Patents

Start-ups

4614

Research Outputs

Impact Stories

CareCoatexTM: A Biomaterial-based Core-Shell Particles for Safe and Effective Antimicrobial Applications

Prof. Li Pei

Textile-based Composite Electrodes For High-Performance Flexible Batteries

Prof. Zheng Zijian

Anti-cancer Drug Candidates Create Commercial and Health Benefits

Prof. Thomas Leung Prof. Larry Chow Prof. Zhao Yanxiang

Nano-based Ink Technology against Counterfeiting and Tampering

Start-up Showcase

Development of a patent-pending microfluidic biochip with fish culture and sensors to detect microbial contamination and pollutants in water and fish.

MicroFish

Design first-in-class antimicrobial medicines that can treat current antibiotic-resistant bacterial infection.

Ynno Med Limited

Focus on developing therapeutics, particularly flavonoid dimers, to target cancer stem cell drug resistance.

Cancer Stem Therapeutics Ltd.

Focus on developing posture training systems for medical, sports, and healthcare applications.

Active Biotechnology (Hong Kong) Company Limited

Focus on biomaterials-based coating applications to provide greener and safer materials. The patented core-shell particle technology platform InnoCoatex™ enables new application on antimicrobial coating.

Grand Rise Technology

Development a new generation of IND-granted arginase for treatment of brain cancer.

PolyMedTech Limited

Developed and licensed reusable medical-graded facemask with an antibacterial and water-repelling outer layer.

Sky Elegant International Limited

Development of highly flexible, and high-energy-density lithium-ion batteries, which are used as embeddable power supply for wearable electronic garments.

EightOSix Technology Company Limited

Development of novel chemical-based bispecific antibody for cancer therapy.

Abismuno Scientific

Development of ABarginase for treatment of metabolic diseases related to obesity and insulin resistance

ABRAM Therapeutics Limited

SF202109143_Website_Angel Fund Team_template_clean_20220628 - Nelson HIM

Focus on developing a revolutionary algae photobioreactor system (PBRs) to absorb and fix carbon dioxide (CO2).

Alcarbo Technology Limited

Development of an indoor eco-system that combines aquaculture and agriculture to produce sustainable aquatic products, fruits, and herbs.

Immortality Aquaponics

Development of a gamification platform that provides training, prevention, monitoring and early detection for dementia patients and older adults.

Medmind Technology Limited

What's New

PolyU Secures HK$32.4 Million RGC Funding for Next-Generation Cancer Immunotherapy Platform: Pioneering PIN-Vax Research

PolyU has received funding support from the Research Grants Council (RGC)’s Strategic Topics Grant (STG) 2025/26 for a multidisciplinary biomedical project. The project aims to develop an integrated technology platform for next-generation cancer immunotherapy. Led by Prof. ZHAO Yanxiang—Associate Head and Professor of PolyU’s Department of Applied Biology and Chemical Technology (ABCT)—this pioneering research addresses some of the most pressing

10 Jul 2025

Polyu Discovers Two Nano Extra-Large-Pore Zeolite Catalysts Using Advanced Materials Development Strategy

Zeolites with crystalline porous structures are the core catalysts in petroleum refining and fine chemical industries. However, current industrial zeolites are large crystal bulk and have small micropores, limiting their applications for decades in the efficient processing of large molecules. Nano extra-large-pore zeolites are the ideal solution to this end but are rather challenging to develop. Now, researchers of The Hong Kong Polytechnic Unive

10 Jul 2025

PolyU’s new Advanced Therapy Product Laboratory gives hope to spinal cord injury patients, supporting Hong Kong’s development into an international health and medical innovation hub

The Hong Kong Polytechnic University (PolyU) strives to promote educational and research development in the fields of medicine and health. Leveraging its state-of-the-art facilities and strengths in interdisciplinary research, the University is committed to supporting Hong Kong’s development into an international health and medical innovation hub by advancing precision medicine and personalised treatment. PolyU will actively promote precision

22 Apr 2025

PolyU-nurtured biopharmaceutical start-up ABRAM accepted by Roche Accelerator

The Hong Kong Polytechnic University (PolyU) celebrates the acceptance of ABRAM Therapeutics Limited (ABRAM), a start-up co-founded by a PolyU scholar, into the Roche Accelerator. This marks the first time a Hong Kong-based start-up being welcomed by this prestigious innovation hub. Nurtured within the PolyVentures start-up ecosystem, ABRAM focuses on its ground-breaking drug candidate, ABarginase, for treating obesity and related metabolic disor

3 Apr 2025

PolyU hosts AI & Medicine: Shaping the Future of Health Forum, featuring a Nobel Laureate and an expert to explore the future of AI-driven medicine

The Hong Kong Polytechnic University (PolyU) Faculty of Computer and Mathematical Sciences, Faculty of Health and Social Sciences, and Faculty of Science today co-hosted the “AI & Medicine: Shaping the Future of Health” Forum. The event featured a keynote speech by Prof. Barry MARSHALL, 2005 Nobel Laureate in Physiology or Medicine, who shared his research journey and provided insights into the future of medicine. Prof. Ya-Qin ZHANG, Chair Profe

27 Mar 2025

Understanding Active Sites in Zeolites: A Step Towards Better Catalysts

Zeolites, crystalline materials widely used in the petrochemical industry, serve as pivotal catalysts in the production of fine chemicals, with aluminium being the source of active sites within zeolite structures. A research team from The Hong Kong Polytechnic University (PolyU) has revealed the precise location of aluminium atoms in the zeolite framework. This discovery could facilitate the design of more efficient and stable catalysts, aimed at

24 Jan 2025

PolyU ABCT Scholars ranked The World’s Top 2 Percent Scientists by Stanford University

Twelve PolyU ABCT staff members are ranked as the World’s Top 2% most-cited scientists 2024 by Stanford University. Using the Scopus author profiles as of 16 September 2024, Stanford University released the latest top 2% scientists in various scientific fields. The list was prepared by Prof. John Ioannidis and his team from Stanford University, the updated database (version 7) provides standardized information on citations, h-index, co-author

18 Oct 2024

Blue Simple and Modern Editable Economic Headline News Facebook Post 1000 525

Congratulations to Prof. Ka Fu YUNG, Prof. Kin Wah LEE, Prof. Zhong Ping YAO, and Prof. Su Ting HAN for receiving funding support from RGC Collaborative Research Fund 2024/25

The Hong Kong Polytechnic University (PolyU) is committed to advancing impactful research through its robust interdisciplinary collaborations and pioneering innovative solutions that benefit the world. In the latest 2024/25 grants from the Research Grants Council (RGC), PolyU has secured funding for 14 projects, including 8 Collaborative Research Project Grant (CRPG) projects, 3 Collaborative Research Equipment Grant (CREG) projects, and 3 Young

3 Jan 2025

Post Image - RGC Collaborative Research Fund 202425

Professor Yan Xiang ZHAO was awarded Research Impact Fund (RIF) 2024/25

We are pleased to announce that Prof. ZHAO Yanxiang, Associate Head and Professor in the Department of Applied Biology and Chemical Technology at The Hong Kong Polytechnic University, has successfully secured funding from the RGC Research Impact Fund (RIF). The RIF encourages academics to harness the potential of their research to deliver benefits to the wider community, spurring impactful and translational research projects.

3 Jan 2025